Upper Limb Spasticity in Adults

Demonstrated Safety in Adults with Upper Limb Spasticity

  • In 2 clinical trials with total doses of 400 Units, most patients experienced mild to moderate adverse reactions1

Learn More About Dosing

Reference

  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2021.